Back to News
Market Impact: 0.15
Priveterra Acquisition Corp. II Amends Milestone Warrants to Reduce Exercise Price
Source: Nasdaq
IPOs & SPACsLegal & Litigation
Priveterra Acquisition Corp. II, filing as AEON Biopharma, Inc., entered into an amendment to a two-year milestone warrant agreement on November 2, 2026. The amendment was executed with holders representing at least 67% of the shares of Common; the available article text does not specify the amendment’s terms or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
AEON0.00
More News
- Aeon Biopharma amends warrant terms, expects $6.2 million in proceeds
- Meta says automation wrongly took down No Kings and a Senate candidate’s page. It’s automating more anyway
- Baron & Budd and Douglas & London Obtain $7.350 Billion Settlement With 3M Company to Resolve PFAS Personal Injury Lawsuits
- Booking Holdings takes $1 billion hit to third-quarter results linked to FTC action
- OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a ‘trend’ of it pivoting resources to defense projects
- Berkshire-owned utility’s wildfire lawsuits head to Oregon Supreme Court